Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 6Pancreatic Neoplasms 4Multiple Myeloma 4Neoplasms, Plasma Cell 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Sarcoma 1Recurrence 1Rectal Diseases 1Ovarian Neoplasms 1Neoplasms by Site 1Liver Neoplasms 1Intestinal Neoplasms 1Intestinal Diseases 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Digestive System Neoplasms 1Digestive System Diseases 1Colorectal Neoplasms 1Colonic Neoplasms 1Colonic Diseases 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Irinotecan 35,10-methylenetetrahydrofolic acid 3repotrectinib 1pralsetinib 1Pemetrexed 1Oxaliplatin 1Levoleucovorin 1Leucovorin 1KRN-330 1Injections 1Fluorouracil 1Bevacizumab 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Intestinal Neoplasms × Ascorbic Acid × Clear all
NCT01550510 2025-05-06

Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA

Thomas Jefferson University

Phase 1/2 Terminated
4 enrolled 5 charts
Gastrointestinal

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡